Elevance Health, Inc.
ELV
$448.74
-$3.95-0.87%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 4.84% | 4.87% | 10.60% | 9.38% | 9.31% |
| Total Other Revenue | 18.03% | 21.40% | 28.83% | 19.54% | 8.24% |
| Total Revenue | 6.80% | 7.29% | 13.05% | 10.70% | 9.15% |
| Cost of Revenue | 3.77% | 4.03% | 9.76% | 9.05% | 9.65% |
| Gross Profit | 16.17% | 16.40% | 22.68% | 15.43% | 7.64% |
| SG&A Expenses | 6.34% | 18.04% | 24.57% | 14.57% | 15.40% |
| Depreciation & Amortization | -12.15% | -5.78% | 33.13% | 82.17% | 82.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.21% | 6.93% | 12.86% | 10.44% | 11.11% |
| Operating Income | 82.54% | 12.95% | 15.97% | 14.48% | -27.99% |
| Income Before Tax | -4.21% | -22.24% | 15.03% | 13.57% | -25.36% |
| Income Tax Expenses | 1.19% | -33.08% | 19.88% | 16.70% | -38.91% |
| Earnings from Continuing Operations | -5.25% | -18.65% | 13.59% | 12.65% | -22.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 308.33% | -320.00% | -200.00% | -250.00% | -200.00% |
| Net Income | -1.04% | -19.59% | 13.19% | 11.18% | -23.92% |
| EBIT | 82.54% | 12.95% | 15.97% | 14.48% | -27.99% |
| EBITDA | 57.99% | 9.96% | 15.13% | 16.30% | -18.23% |
| EPS Basic | 1.23% | -18.12% | 15.16% | 13.01% | -22.57% |
| Normalized Basic EPS | 109.91% | 12.86% | 16.53% | 13.59% | -34.08% |
| EPS Diluted | 1.22% | -17.67% | 15.75% | 13.39% | -22.57% |
| Normalized Diluted EPS | 109.91% | 13.51% | 17.25% | 13.95% | -34.08% |
| Average Basic Shares Outstanding | -2.24% | -1.79% | -1.70% | -1.62% | -1.75% |
| Average Diluted Shares Outstanding | -2.24% | -2.35% | -2.30% | -1.92% | -1.75% |
| Dividend Per Share | 15.63% | 15.63% | 15.63% | 15.63% | 13.27% |
| Payout Ratio | 0.15% | 0.41% | 0.00% | 0.02% | 0.47% |
